7d0f6512 83e7 4bd7 B10e Ef6dc183be82 01
Sodium Nitroprusside is a chemical compound represented by the formula 2Na* | NC CN | * 2H0.*
Sodium Nitroprusside Injection, Solution, Concentrate
Product Images NDC 70069-261
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 70069-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
7d0f6512 83e7 4bd7 B10e Ef6dc183be82 02
The text describes the metabolism of Sodium Nitroprusside through the conversion of cytochromes and thiosulfate. It also mentions the production of thiocyanate as a byproduct, which is excreted via the renal system. Overall, it provides a basic understanding of the breakdown of Sodium Nitroprusside in the body.*
7d0f6512 83e7 4bd7 B10e Ef6dc183be82 03
7d0f6512 83e7 4bd7 B10e Ef6dc183be82 04
This is a prescription-only drug called Sodium Nitroprusside Injection. The injection comes in 2mL single-dose vials and each vial contains 50mg of Sodium Nitroprusside. It must be diluted before use in 250 to 1000 mL of 5% dextrose. This is a potent drug that needs to be monitored by checking blood pressure before and during administration. It is for intravenous infusion only, and not for direct injection. The drug must be protected from light and the solution should be discarded within 24 hours of dilution. The drug is manufactured by Somerset Therapeutics, LLC in India. The prescription package insert must be consulted for dosing and other administration information.*
7d0f6512 83e7 4bd7 B10e Ef6dc183be82 05
This is a description for Sodium Nitroprusside injection, which comes in a solution that needs to be diluted in a specific ratio with 5% Dextrose Injection, USP. The description mentions that this solution needs to be protected from light, and that the solution should be discarded 24 hours after dilution. Other medications should not be added to this solution. The product is manufactured in India and distributed by Somerset Therapeutics LLC. Additional instructions for use are included in an enclosure.*
7d0f6512 83e7 4bd7 B10e Ef6dc183be82 06
This is a medication packaging that includes a light protective sleeve for Sodium Nitroprusside infusion solution. It is important to protect the infusion from light by using the enclosed sleeve or any other opaque material. The information was last revised in November 2019. The product code is ST-SNP11/SC/01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
